RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.26% | -13.24% | -14.05% | -3.89% | 10.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.26% | -13.24% | -14.05% | -3.89% | 10.75% |
| Cost of Revenue | -18.20% | -27.38% | -29.77% | -23.21% | -12.18% |
| Gross Profit | -12.94% | -8.05% | -7.89% | 4.11% | 21.32% |
| SG&A Expenses | 3.65% | 5.21% | 8.47% | 10.97% | 19.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.29% | -3.64% | -1.27% | 3.33% | 12.07% |
| Operating Income | -35.11% | -29.59% | -50.15% | -30.75% | -16.38% |
| Income Before Tax | -49.28% | -45.57% | -75.89% | -41.87% | -16.25% |
| Income Tax Expenses | 76.39% | 45.33% | -10.17% | 30.00% | 260.00% |
| Earnings from Continuing Operations | -49.33% | -45.57% | -75.69% | -41.85% | -16.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.33% | -45.57% | -75.69% | -41.85% | -16.41% |
| EBIT | -35.11% | -29.59% | -50.15% | -30.75% | -16.38% |
| EBITDA | -35.93% | -31.16% | -54.72% | -34.99% | -21.68% |
| EPS Basic | -46.60% | -42.62% | -70.35% | -34.00% | -7.15% |
| Normalized Basic EPS | -46.51% | -42.58% | -70.49% | -33.99% | -7.01% |
| EPS Diluted | -46.60% | -42.62% | -70.35% | -34.00% | -7.15% |
| Normalized Diluted EPS | -46.51% | -42.58% | -70.49% | -33.99% | -7.01% |
| Average Basic Shares Outstanding | 1.91% | 2.19% | 3.19% | 5.11% | 7.63% |
| Average Diluted Shares Outstanding | 1.91% | 2.19% | 3.19% | 5.11% | 7.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |